COMMUNIQUÉS West-GlobeNewswire

Vistin Pharma ASA : Share capital increase registered
09/05/2018
Oslo, Norway, 9 May 2018 Vistin Pharma ASA (OSE: VISTIN), reference is made to the Company's announcements on 8 May regarding the approval by the annual general meeting of the Private Placement of 26,785,715 shares at a [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 8 May 2018
09/05/2018
Bagsværd, Denmark, 9 May 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of [...]
Trading by management and close relations of management
09/05/2018
Read the full announcement in the attached file Attachment 2018_29_Trading_by_management_EN
Nexstim Plc launches NBT® system for depression at the US Clinical TMS Society Annual Meeting in New York
09/05/2018
Press release, Helsinki, 9 May 2018, at 12 noon NBT ® system is the only FDA approved personalised navigation approach for accurate targeted brain stimulation in therapy Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or [...]
Cytovance® Biologics Successfully Completes FDA Inspection
09/05/2018
OKLAHOMA CITY, May 09, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract development and manufacturing services company is pleased to announce the United States Food [...]
Insider's tradings
09/05/2018
Nasdaq Copenhagen 9 May 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the [...]
Solon Eiendom ASA : Invitation to presentation of first quarter 2018 results
09/05/2018
Oslo, 09 May 2018 - Solon Eiendom ASA will publish its first quarter 2018 results on Wednesday 16 May at 08.00 am CET. The quarterly report and the presentation will be available on the company's web site, www. [...]
Bone Therapeutics SA : The preliminary documents for the Annual Ordinary and the Extraordinary General Shareholder Meeting on 13 June 2018 have been made available
09/05/2018
Regulated information The preliminary documents for the Annual Ordinary and the Extraordinary General Shareholder Meeting on 13 June 2018 have been made available Gosselies, Belgium, 9 May 2018, 8am CEST - BONE [...]
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l'assemblée générale ordinaire et à l'assemblée générale extraordinaire du 13 juin 2018
09/05/2018
Information réglementée Mise à disposition des documents préparatoires à l'assemblée générale ordinaire et à l'assemblée générale extraordinaire du 13 juin 2018 Gosselies, Belgique, le 9 mai 2018, 8h00 CEST - BONE [...]
Shire plc : Rule 2.9 Announcement
09/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 9 May 2018 Shire [...]
Motif Bio Appoints Stephanie Noviello, MD, MPH as Vice President, Clinical Development
09/05/2018
NEW YORK, May 09, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that Stephanie Noviello, MD, [...]
ThromboGenics Business Update - Q1 2018
09/05/2018
Press release 9 May 2018 Regulated Information Advancing Diabetic Eye Disease Portfolio Positive Initial Topline Data from Phase 1/ 2a Clinical Study evaluating THR-317, anti-PlGF, for the Treatment of Diabetic Macular [...]
ERYTECH to Host First Quarter 2018 Conference Call and Business Update
09/05/2018
LYON, France, May 09, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]
Curetis to Hold Annual General Shareholders' Meeting on June 21, 2018
09/05/2018
Curetis to Hold Annual General Shareholders' Meeting on June 21, 2018 Amsterdam, the Netherlands, Holzgerlingen, Germany and San Diego, CA, USA, May 9, 2018, 07:00 am CEST / 01:00 am EDT - Curetis N.V. (the " Company " [...]
IBA SA : IBA Business Update - First Quarter 2018
09/05/2018
IBA Business Update - First Quarter 2018 21 ongoing proton therapy projects in 2018 Louvain-La-Neuve, Belgium, 9 May 2018 - IBA (Ion Beam Applications S.A., EURONEXT), the world's leading provider of proton therapy [...]
IBA SA : IBA Déclaration Intermédiaire - Premier Trimestre 2018
09/05/2018
IBA Déclaration Intermédiaire - Premier Trimestre 2018 21 projets de protonthérapie en cours d'installation en 2018 Louvain-La-Neuve, Belgique, 9 mai 2018 - IBA ( Ion Beam Applications SA , EURONEXT), le premier [...]
argenx reports first quarter 2018 financial results and provides business update
09/05/2018
May 9, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment [...]
Medibio Corporate Health contract signed with Australia’s 3rd largest private healthcare provider
09/05/2018
SYDNEY, Australia and MINNEAPOLIS, May 08, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced the execution of a commercial [...]
Evelo Biosciences Announces Pricing of Initial Public Offering
09/05/2018
CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO ) (“Evelo”) today announced the pricing of its initial public offering of 5,312,500 shares of common stock at a public offering [...]

Pages